Centrus Energy Corp vs 22nd Century Group Inc — how do they compare? Centrus Energy Corp trades at $142.02 (market cap $2.91B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Centrus Energy Corp is far larger — about 4680.9× 22nd Century Group Inc's market cap, and Centrus Energy Corp is more actively traded (903,777 versus 45,625). Which is the better fit depends on your goals — on Pluang, investors hold Centrus Energy Corp for 29 Days and 22nd Century Group Inc for 32 Days on average.
| LEU | XXII | |
|---|---|---|
Market Cap | $2.91B | $621.67K |
Volume | 903,777 | 45,625 |
Sector | Energy | Consumer Staples |
52-Week High | $436.00 | $483.00 |
52-Week Low | $138.18 | $0.80 |
Typical Hold Time | 29 Days | 32 Days |
Enterprise Value | $2.22B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Centrus Energy (LEU) trades at $143.88, down 2.22% on the day, with a bearish technical outlook despite recent earnings beats. The stock shows elevated valuation metrics (P/E 75.18) but maintains profitability with 10.23% net margins. Recent news highlights Centrus' strategic position as the only US-licensed HALEU producer, benefiting from nuclear energy growth and Russian uranium import bans.
The investment case balances high growth potential in nuclear fuel supply against execution risks and premium valuation. Analyst consensus at $218.10 suggests 52% upside, but technical indicators and recent equity dilution from a $500 million offering present near-term headwinds. Success depends on contract execution and nuclear industry adoption timelines.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →